Bis{μ‐2‐[(1,5‐diaza‐1‐cyclooctyl)methyl]phenolato‐N,N′,O:O}bis[chlorozinc(II)] diacetone solvate: design of a square‐pyramidal ZnN2O2Cl complex

The title complex, [Zn₂(C₁₃H₁₉N₂O)₂Cl₂]·2C₃H₆O, resides on a crystallographic inversion center. The two Zn^II centers bridged by the phenoxo groups are in pentacoordinated distorted square‐pyramidal coordination environments with an intramolecular Zn?Zn distance of 3.175 (3) Å. The mesocyclic ligand takes a boat–chair conformation and an H atom from the 1,5‐di­aza­cyclo­octane ring effectively blocks the axial coordination site opposite the Cl ligand to form the ZnN₂O₂Cl geometry. The crystal structure is stabilized by a N—H?O hydrogen bond between the amino group and an acetone mol­ecule.     

[1,5‐Bis(1‐methyl‐1H‐imidazol‐2‐yl­methyl‐κN3)‐1,5‐di­aza­cyclo­octane‐N,N′]chlorocobalt(II) perchlorate

The crystal structure of the title compound, [CoCl‐(C₁₆H₂₆N₆)]ClO₄, consists of discrete [CoCl­(C₁₆­H₂₆N₆)]⁺ cations and perchlorate anions. The five‐coordinate Co^II atom has four nitro­gen donors from the new mesocyclic ligand 1,5‐bis(1‐methyl‐1H‐­imidazol‐2‐ylmethyl)‐1,5‐di­aza­cyclo­octane [Co—N 2.046 (3)–2.214 (4) Å], and a chloride anion at the apical site [Co—Cl 2.3184 (13) Å]. The coordination geometry of the complex is essentially square pyramidal. The mesocyclic ligand takes a boat–chair configuration and the two imidazole pendants are not coplanar. The dihedral angle between the two imidazole planes is 15.97°. An H atom from the 1,5‐diaza­cyclo­octane group effectively blocks the axial coordination site opposite the Cl ligand.     

The 1:1 adduct of 5‐methylbenzene‐1,3‐diol (orcin) and 1,4‐di­aza­bicyclo­[2.2.2]­octane

In the title adduct, C₆H₁₂N₂·C₇H₈O₂, the orcin and 1,4‐di­aza­bi­cyclo­[2.2.2]­octane moieties are held together by O—H⋯N hydrogen bonds. One‐dimensional chiral hydrogen‐bonded chains are formed along the b axis. Neighbouring chains are held together principally by van der Waals interactions and are interrelated by translation, resulting in a chiral layer.     

Bis(1,5‐di­aza­cyclo­octane‐N,N′)nickel(II) dibromide

The crystal structure of the title complex, [Ni(C₆H₁₄N₂)₂]Br₂, consists of discrete [Ni(C₆H₁₄N₂)₂]²⁺ cations and bromide counter‐anions. The Ni^II ion is at the center of symmetry and is four‐coordinated by four nitro­gen donors of the mesocyclic ligand 1,5‐di­aza­cyclo­octane (DACO) [Ni—N 1.935 (2)–1.937 (2) Å]. The coordination geometry of Ni^II can be considered as square planar and both DACO ligands take the boat–chair conformation. The bromide anions are hydrogen bonded with the nitro­gen donors of the ligands to form a macrocycle‐like ring system.     

Di­aza­bi­cyclo­[2.2.2]­octane‐1,4‐diium dichromate

The title compound, (C₆H₁₄N₂)[Cr₂O₇], consists of a di­aza­bi­cyclo­[2.2.2]­octane‐1,4‐diium cation and a discrete dichromate anion, which are linked in the crystal by N—H⋯O hydrogen bonds. The cation is ordered and distorted, owing to the confinement and twist of the hydrogen bonds involved. Two CrO₄ tetrahedra are joined through a shared O atom to form the dichromate anion. Chiral supramolecular chains of the title compound are built up via N—H⋯O hydrogen bonds, and C—H⋯O interactions play subordinate roles in forming the structure.     

1,4‐Di­aza­bi­cyclo­[2.2.2]­octane‐1,4‐diium trichromate

The title compound, (C₆H₁₄N₂)[Cr₃O₁₀], consists of a di­aza­bi­cyclo­[2.2.2]­octane‐1,4‐diium cation and a discrete trichromate anion linked by an N—H⋯O hydrogen bond. Three CrO₄ tetrahedra are joined via shared O atoms to form the trichromate anion. Supramolecular rings, which can be described by the graph‐set motif (26), are built via N—H⋯O hydrogen bonds, and C—H⋯O interactions play lesser roles in forming the structure.     

Two isomers of 2,4‐di­benzyl‐8‐azabicyclo­[3.2.1]­octan‐3‐ol

The crystal structures of the title compounds, 2α,4α‐di­benzyl‐3α‐tropanol (2α,4α‐di­benzyl‐8‐methyl‐8‐aza­bi­cyclo­[3.2.1]­octan‐3α‐ol), C₂₂H₂₇NO, (I), and 2α,4α‐di­benzyl‐3β‐tropanol (2α,4α‐di­benzyl‐8‐methyl‐8‐aza­bi­cyclo­[3.2.1]­octan‐3β‐ol), C₂₂H₂₇NO, (II), show that both compounds have a piperidine ring in a chair conformation and a pyrrolidine ring in an envelope conformation. Isomer (I) is asymmetric, the benzyl groups having different orientations, whereas isomer (II) is mirror symmetric, and the N and O atoms, the C atom attached to the hydroxy group, and the methyl C atom attached to the N atom lie on the mirror plane. In the crystal structures of both (I) and (II), the mol­ecules are linked together by intermolecular O—H⋯N hydrogen bonds to form chains that run parallel to the a direction in (I) and parallel to b in (II).     

The 2:1 complex of maleic acid and 1,4‐diazabicyclo[2.2.2]octane: hydrogen‐bonded sheets linked by C–H⋯O hydrogen bonds

In the title complex, 1,4‐diazo­niabi­cyclo­[2.2.2]­octane bis­(hy­drogen maleate), C₆H₁₄N₂²⁺·2C₄H₃O₄^?, the C₄H₃O₄^? and C₆H₁₄N₂²⁺ ions, derived from maleic acid and 1,4‐di­aza­bi­cyclo­[2.2.2]­octane, respectively, are disordered across a mirror plane in space group Cmc2₁, and they are linked by two nearly linear N—H?O hydrogen bonds, with N?O distances of 2.662 (3) and 2.614 (4) Å, and N—H?O angles of 173°. The crystal structure consists of sheets with reticulations of 3.3792 (4) Å in stratum and 7.3892 (8) Å in width. The sheets are linked by C—H?O hydrogen bonds.     

Intramolecular cyclization of 4,7‐bis(2‐bromo­acetyl)‐1‐thia‐4,7‐di­azacyclo­nonane

The reaction of 1‐thia‐4,7‐di­azacyclo­nonane with bromo­acetyl bromide in CHCl₃ affords the unexpected salt 4‐(2‐bromo­acetyl)‐8‐oxo‐1‐thionia‐4,7‐di­aza­bi­cyclo­[5.2.2]­un­decane bromide, C₁₀H₁₆BrN₂O₂S⁺·Br⁻. Two units of the salt are linked by S⋯Br contacts about a crystallographic inversion centre, thus forming dimers that are linked by Br⋯Br contacts into extended ribbons. S⋯O contacts between these ribbons generate a two‐dimensional sheet.     

A zinc–lithium complex of 4,7‐bis(2‐aminoethyl)‐1,4,7‐triazacyclononane‐1‐acetate

The asymmetric unit of {[4,7‐bis(2‐amino­ethyl)‐1,4,7‐tri­aza­cyclo­nonan‐1‐yl]acetato}zinc(II) triaqua{μ‐[4,7‐bis(2‐amino­ethyl)‐1,4,7‐tri­aza­cyclo­nonan‐1‐yl]acetato}lithium(I)zinc(II) chloride diperchlorate, [Zn(C₁₂H₂₆N₅O₂)][LiZn(C₁₂H₂₆N₅O₂)(H₂O)₃]Cl(ClO₄)₂, obtained from the reaction between the lithium salt of 4,7‐bis(2‐amino­ethyl)‐1,4,7‐tri­aza­cyclo­nonane‐1‐acetate and Zn(ClO₄)₂, contains two Zn^II complexes in which each Zn^II ion is six‐coordinated by five N‐atom donors and one O‐­atom donor from the ligand. One carboxyl­ate O‐atom donor is not involved in coordination to a Zn^II atom, but coordinates to an Li⁺ ion, the tetrahedral geometry of Li⁺ being completed by three water mol­ecules. The two complexes are linked via a hydrogen bond between a primary amine N—H group and the carboxyl­ate‐O atom not involved in coordination to a metal.     

Dicarbonyldi‐μ‐chloro‐cis,cis‐η4‐1,5‐cyclo­octa­dienedirhodium(I)

The title compound, dicarbonyl‐1κ²C‐di‐μ‐chloro‐1:2κ⁴Cl‐[cis,cis‐2(η⁴)‐1,5‐cyclo­octa­diene]­di­rhodium(I), [Rh₂Cl₂(C₈H₁₂)(CO)₂], consists of a di­chloro‐bridged dimer of rhodium, with a non‐bonded Rh?Rh distance of 3.284 (2) Å. One Rh atom is coordinated to two carbonyl ligands, while the other Rh atom is coordinated to the cyclo­octa­diene moiety.     

μ‐Cyano‐1:2κ2C:N‐tetracyano‐1κ4C‐(5‐methyl‐5‐nitro‐3,7‐diazanonane‐1,9‐diamine‐2κ4N1,3,7,9)‐nitrosyl‐1κN‐copper(II)iron(II) dihydrate

The title binuclear complex, [CuFe(CN)₅(C₈H₂₁N₅O₂)(NO)]·2H₂O or [CuFe(nelin)(CN)₅(NO)]·2H₂O (nelin is 5‐methyl‐5‐nitro‐3,7‐di­aza­nonane‐1,9‐di­amine) consists of discrete binuclear mixed‐metal species, with a Cu centre linked to an Fe centre through a cyano bridge, and two water mol­ecules of crystallization. In the complex, the Cu^II ion is coordinated by five N atoms and has a distorted square‐pyramidal geometry. The Fe^II centre is in a distorted octahedral environment.     

Bis(μ‐pyridine‐2,6‐carboxyl­ato‐O,N,O′:O)­bis­[tri­aqua­manganese(II)]–pyridine‐2,6‐di­carboxylic acid (1/2)

In the structure of the title compound, [Mn₂(C₇H₃NO₄)₂(H₂O)₆]·2C₇H₅NO₄, a centrosymmetric dinuclear complex, hexaa­aqua­bis­(pyri­dine‐2,6‐di­carboxyl­ato)­dimanganese(II) and free pyri­dine‐2,6‐di­carboxyl­ic acid are present in a 1:2 ratio. In the complex, each Mn²⁺ ion is coordinated by three O atoms and one N atom from the pyridine‐2,6‐di­carboxyl­ate ligands and by three water O atoms, resulting in a distorted pentagonal bipyramidal coordination. Within the centrosymmetric dinuclear complex, two Mn²⁺ ions are bridged by two carboxyl­ate O atoms. The crystal structure is stabilized by hydrogen bonds involving all the H atoms of the water ligands.     

cis‐Di­chloro(5,8‐dioxa‐2,11‐dithia[12]‐o‐cyclo­phane)­palladium(II)

The preparation and crystal structure of the title compound, cis‐di­chloro­[6,9‐dioxa‐3,12‐di­thia­bi­cyclo­[12.4.0]­octadeca‐14,‐16,­18(1)‐tri­ene‐S,S′]­palladium(II), [PdCl₂(C₁₄H₂₀O₂S₂)], are described. The Pd atom has a square‐planar environment, coordinated to two S atoms of the di­thia­dioxa macrocycle and to two Cl^? ions. The non‐coordinating O atoms are oriented away from the metal coordination plane. Upon complexation, a bicyclic chelate structure, which consists of a seven‐ and an eleven‐membered ring, is formed.     

trans‐[N,N′‐Bis­(salicyl­idene)­cyclo­hexane‐1,2‐diaminato]­nickel(II)–chloro­form (1/1)

In the title complex, trans‐{2,2′‐[cyclo­hexane‐1,2‐diyl­bis­(ni­t­rilo­methyl­idyne)]­di­phenol­ato‐κ⁴O,N,N′,O′}­nickel(II)–chloro­form (1/1), [Ni(C₂₀H₂₀N₂O₂)]·CHCl₃, the Ni atom has a square‐planar geometry, slightly tetrahedrally distorted. The Ni—N and Ni—O bonding distances are within the expected ranges for Ni–Schiff base derivatives. The di­imine bridge has a gauche conformation with the cyclo­hexyl ring almost coplanar with the NiN₂O₂ plane. The complex mol­ecules pack in dimers with an Ni?Ni distance of 3.59 (1) Å and form a three‐dimensional structure displaying a herring‐bone configuration. Channels are occupied by solvent mol­ecules, which are involved in C—H?O hydrogen bonds with the ligand O atoms.     

Precursor of a β‐lactamase inhibitor: allyl (4S,8S,9R)‐10‐[(E)‐ethyl­idene]‐4‐methoxy‐11‐oxo‐1‐aza­tri­cyclo­[7.2.0.03,8]­undec‐2‐ene‐2‐carboxyl­ate

The molecular structure of the title tricyclic compound, C₁₇H₂₁NO₄, which is the immediate precursor of a potent synthetic inhibitor {Lek157: sodium (8S,9R)‐10‐[(E)‐ethyl­idene]‐4‐methoxy‐11‐oxo‐1‐aza­tri­cyclo­[7.2.0.0^3,8]­undec‐2‐ene‐2‐carboxyl­ate} with remarkable potency, provides experimental evidence for the previously modelled relative position of the fused cyclo­hexyl ring and the carbonyl group of the β‐lactam ring, which takes part in the formation of the initial tetrahedral acyl–enzyme complex. In this hydro­phobic mol­ecule, the overall geometry is influenced by C—H?O intramolecular hydrogen bonds [3.046 (4) and 3.538 (6) Å, with corresponding normalized H?O distances of 2.30 and 2.46 Å], whereas the mol­ecules are interconnected through intermolecular C—H?O hydrogen bonds [3.335 (4)–3.575 (5) Å].     

Threefold interweaving of (4,4) nets built from R(58) rings in the hydrogen‐bonded adduct 1,4‐diaza­bicyclo[2.2.2]octane–5‐hydroxy­isophthalic acid (1/1)

The 1:1 adduct of 1,4‐di­aza­bi­cyclo­[2.2.2]­octane and 5‐hydroxy­isophthalic acid is a salt, [H(C₆H₁₂N₂)]⁺·­[HOC₆H₃(COOH)COO]^? or C₆H₁₃N₂⁺·C₈H₅O₅^?. The ions are linked by three types of hydrogen bond, i.e. N—H?O, O—H?O and O—H?N, into continuous two‐dimensional (4,4) nets built from a single type of R(58) ring. Six independent sheets of this type make up the structure and these are interwoven in sets of three.     

Di‐μ‐sulfido‐bis[diaqua(18‐crown‐6)­barium(II)]–saccharin (1/2)

The mol­ecule of the title compound {systematic name: di‐μ‐sulfido‐bis[di­aqua(1,4,7,10,13,16‐hexaoxa­cyclo­octade­cane‐κ⁶O)barium(II)] bis­[1,2‐benzisothiazol‐3(2H)‐one 1,1‐dioxide]}, [Ba₂S₂(C₁₂H₂₄O₆)₂(H₂O)₄](C₇H₅NO₃S)₂, lies on an inversion centre. The Ba^II atom encapsulated by the 18‐crown‐6 ring is coordinated by the six O atoms of the crown, two water O atoms and two bridging S atoms. The four‐membered ring composed of the Ba^II atoms and the bridging S atoms makes a dihedral angle of 67.1 (1)° with the crown‐ether ring. The aromatic ring system of the saccharin moiety is essentially planar. The packing is built up from layers of the mol­ecules and is stabilized by three intermolecular O—H?O hydrogen bonds.     

Four cyclo­alkane­spiro‐4′‐imidazolidine‐2′,5′‐dithiones

The crystal structures of four cyclo­alkane­spiro‐4′‐imidazolidine‐2′,5′‐dithiones, namely cyclo­pentane­spiro‐4′‐imidazolidine‐2′,5′‐dithione {systematic name: 1,3‐diaza­spiro­[4.4]­nonane‐2,4‐dithione}, C₇H₁₀N₂S₂, cyclo­hexane­spiro‐4′‐imidazolidine‐2′,5′‐dithione {systematic name: 1,3‐diaza­spiro­[4.5]decane‐2,4‐dithione}, C₈H₁₂N₂S₂, cyclo­heptane­spiro‐4′‐imidazolidine‐2′,5′‐dithione {systematic name: 1,3‐diaza­spiro­[4.6]undecane‐2,4‐dithione}, C₉H₁₄N₂S₂, and cyclo­octane­spiro‐4′‐imidazolidine‐2′,5′‐dithione {systematic name: 1,3‐di­aza­spiro­[4.7]dodecane‐2,4‐dithione}, C₁₀H₁₆N₂S₂, have been determined. The three‐dimensional packing in all of the structures is based on closely similar chains, in which hydantoin moieties are linked through N—H⋯S hydrogen bonding. The size of the cyclo­alkane moiety influences the degree of its deformation. In the cyclo­octane compound, the cyclo­octane ring assumes both boat–chair and boat–boat conformations.     

A 1,2,4‐diazaphospholane complex of rhodium

The crystal structure of a prospective olefin catalyst, namely {2‐[1‐acetyl‐5‐(2‐hydroxy­phenyl)‐4‐phenyl‐1,2,4‐di­aza­phospholan‐3‐yl]­phenyl acetate‐κP}chloro­(η⁴‐cyclo­octa‐1,5‐diene)rhodium(I) di­chloro­methane solvate, [RhCl(C₈H₁₂)(C₂₄H₂₃N₂O₄P)]·CH₂Cl₂, has been determined at 173 K. The five‐membered heterocycle of the phosphine ligand is in a slightly distorted twist conformation. An intramolecular N1—H1⃛Cl1 hydrogen bond contributes to the adopted conformation and may additionally participate in secondary interactions with substrates during catalysis.